Structural features of heterotrimeric G-protein-coupled receptors and their modulatory proteins.

Quantification of beta-sheet amyloid fibril structures with thioflavin T.

Screening for pharmacologic inhibitors of amyloid fibril formation.

125I-labeled ApoE binds competitively to beta(1-40) fibrils with pathological chaperone proteins.

125I-labeled ApoE binds competitively to beta(1-40) fibrils with pathological chaperone proteins.

[Anonymous].  2000.  125I-labeled ApoE binds competitively to beta(1-40) fibrils with pathological chaperone proteins.. Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis. 7(2):83-9.

The cerebral proteopathies.

Proteopathy: the next therapeutic frontier?

4,4(')-Dianilino-1,1(')-binaphthyl-5,5(')-disulfonate: report on non-beta-sheet conformers of Alzheimer's peptide beta(1-40).

Challenges of targeting A beta fibrillogenesis and other protein folding disorders.

The Amyloid Hypothesis and the clearance and degradation of Alzheimer's beta-peptide.

Refinement of a homology model of the mu-opioid receptor using distance constraints from intrinsic and engineered zinc-binding sites.